Micro-and nanocarriers for pain alleviation
A da Silva, S Lepetre-Mouelhi, P Couvreur - Advanced Drug Delivery …, 2022 - Elsevier
Acute or chronic pain is a major source of impairment in quality of life and affects a
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
[PDF][PDF] Micro-and nanocarriers for pain alleviation
A da Silva, S Lepetre-Mouelhi… - Advanced …, 2022 - universite-paris-saclay.hal.science
Acute or chronic pain is a major source of impairment in quality of life and affects a
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
Micro-and nanocarriers for pain alleviation
A da Silva, S Lepetre-Mouelhi… - … drug delivery reviews, 2022 - pubmed.ncbi.nlm.nih.gov
Acute or chronic pain is a major source of impairment in quality of life and affects a
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
[引用][C] Micro-and nanocarriers for pain alleviation
A da Silva, S Lepetre-Mouelhi… - Advanced Drug Delivery …, 2022 - cnrs.hal.science
Micro- and nanocarriers for pain alleviation - CNRS - Centre national de la recherche
scientifique Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) Se …
scientifique Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) Se …
Micro-and nanocarriers for pain alleviation.
A da Silva, S Lepetre-Mouelhi… - Advanced Drug Delivery …, 2022 - europepmc.org
Acute or chronic pain is a major source of impairment in quality of life and affects a
substantial part of the population. To date, pain is alleviated by a limited range of treatments …
substantial part of the population. To date, pain is alleviated by a limited range of treatments …